Postbiotics as a therapeutic frontier in Parkinson’s disease: Insights into molecular pathways and neuroprotective effects

This publication has 99 references indexed in Scilit:

• Exploring Fecal Microbiota Transplantation: Potential Benefits, Associated Risks, and Challenges in Cancer Treatment
  Cancer Reports, 2026
• Short-Chain Fatty Acids as a Therapeutic Strategy in Parkinson’s Disease: Implications for Neurodegeneration
  Cellular and Molecular Neurobiology, 2025
• The Kynurenine Pathway in Gut Permeability and Inflammation
  Inflammation, 2024
• Fecal Microbiota Transplantation for Treatment of Parkinson Disease
  JAMA Neurology, 2024
• Modulation of gut‐microbiota through probiotics and dietary interventions to improve host health
  Journal of the Science of Food and Agriculture, 2024
• The gut microbiota metabolite butyrate mitigates MPTP/MPP⁺‐induced Parkinson's disease by inhibiting the JAK2/STAT3 signaling pathway
  The Kaohsiung Journal of Medical Sciences, 2023
• Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function
  Amino Acids, 2022
• The Vicious Cycle Between α‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction
  Movement Disorders, 2019
• Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management
  Neurological Sciences, 2018
• Lipid Peroxidation and Mitochondrial Dysfunction in Alzheimer's and Parkinson's Diseases: Role of Natural Products as Cytoprotective Agents
  2017